It’s essential to understand how to properly read and analyze the results to unlock accurate and meaningful insights. Whether you’re working with DNA, RNA, or another type of genetic data, investigators must approach datasets thoughtfully, recognize their unique characteristics, and remain alert to any weaknesses that could limit their ability to draw meaningful conclusions.
Copenhagen, Denmark, October 7th, 2024 – Clinical Microbiomics A/S (“CMC”), a leading innovator in multi-omics, bioinformatics and systems biology for the microbiome field, based in Copenhagen, Denmark, announces that the company has entered into a definitive agreement whereby Microba Life Sciences Limited (“Microba”) transfers its Research Services business unit to CMC. The deal supports CMC’s ambition to increase access to...
The microbiome industry is experiencing rapid growth and transformation, driven by advancements in sequencing technologies, increased funding, and innovative research. This blog article compiles 40 key statistics that highlight the significant changes and trends in the microbiome field in 2024. Covering aspects from market size and segmentation to machine learning applications and insights from major...
The human skin microbiome, a complex and diverse ecosystem of microorganisms, plays a crucial role in maintaining healthy skin. Understanding and improving this delicate balance can lead to better skin health and overall well-being. This article delves into the key insights about the skin microbiome and provides actionable tips to enhance it.
In the realm of microbiology, accurately identifying bacterial species is crucial for understanding microbial communities, diagnosing infections, and guiding treatment strategies. Traditional methods of bacterial identification, such as culture-based techniques, have limitations in providing rapid and comprehensive identification, especially for clinically unidentifiable bacterial isolates.
In the realm of microbiology, understanding the intricate workings of microbial communities has become a cornerstone of scientific inquiry. Two powerful tools, metatranscriptomics and metagenomics, have emerged as indispensable techniques for unravelling the complexities of microbial ecosystems. In this article, we delve into the nuances of these methodologies, exploring their differences, advantages, and applications.
Offering Unparalleled Resolution and Quality in Microbial Analysis Copenhagen, Denmark — April 23, 2024 — Clinical Microbiomics, a leader in microbiome analysis, announces the launch of its advanced long-read sequencing services. Tailored to meet the stringent requirements of academic, clinical, and industrial researchers, the expanded offerings deliver unmatched insights into microbial communities, featuring the industry’s...
Durham, NC (March 21, 2024 ) – Resilient Biotics, a leading microbiome platform company with a pipeline of products for maintaining respiratory tract health, is thrilled to announce a groundbreaking collaboration with CosmosID, a renowned microbiome analytics company. This joint effort aims to explore the intricate microbiome strains that colonize the respiratory tract tissues, a...
Clinical Microbiomics A/S^1, the global microbiome science company, today announces the acquisition of DNASense ApS, an innovative Danish microbiome CRO specialized in long-read DNA and RNA sequencing technologies, and the associated cutting-edge bioinformatics.
In the intricate world of microbiology and bacterial identification, 16S sequencing plays a pivotal role. But a common query often perplexes scientists and enthusiasts alike: Does 16S sequencing target RNA or DNA? This article will unravel the mysteries surrounding amplicon sequencing, exploring its role in bacterial identification, the distinction between 16S rRNA and whole genome...
© 2023 CosmosID. All rights reserved